This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Compact view
Research pass: stub-manual Compound WATCH-LIST MEDIUM

Auvelity

Extended Research
Extended Research

Our depth — beyond the mirror

Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.

Editor's verdict WATCH-LIST MEDIUM

First oral rapid-onset antidepressant — Phase 3 (GEMINI, ASCEND) showed response at week 1 vs week 4-6 for SSRIs. For Dylan at 20 with no depression indication, no current case. Important to know because (a) it's a major new MoA in psychiatry, (b) the underlying DXM cough syrup mechanism is being investigated for many other indications, and (c) if mood support ever becomes relevant, this is one of the better modern options vs an SSRI default.

Research pass: stub-manual
Verdict change log
  • 2026-06-05 — Initial verdict WATCH-LIST. (stub)

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…